OPPORTUNITY FOR TESTING INDEX

Live / Registered — Registered (as of 26 Oct 2021)

What this means for you

Registered since 26 Oct 2021. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
88960228
Registration number
6533458
Mark type
Stylized text
Filed
11 Jun 2020
Published for opposition
10 Aug 2021
Registered
26 Oct 2021
Attorney of record
MARGARET M. POWERS

Goods and services

  • Class 005 — Pharmaceuticals: Diagnostic testing materials in the nature of reagents for medical use; Medical diagnostic reagents and assays for testing of body fluids; Reagents for use in diagnostic tests for medical purposes
  • Class 009 — Scientific and electric apparatus: Downloadable computer software for use in relation to medicine and pharmaceutical research and development services for data management, data analysis, data manipulation; downloadable computer software used to connect laboratory networks and diagnostic and pharmaceutical companies; downloadable computer software used to analyse data in the field of medicine and pharmaceutical testing, research and development; downloadable computer software for use in relation to business networking and content management in the field of medicine and pharmaceutical testing, research and development; downloadable computer software applications for data management and visualisation, for generating reports, charts and dashboards in the field of medicine and pharmaceutical research and development
  • Class 042 — Scientific and technological services: Pharmaceutical drug development services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; research relating to medicines; testing of pharmaceuticals; computer aided diagnostic testing services, namely, computer-aided diagnostic product testing; design and development of medical diagnostic apparatus; research and development in the field of diagnostic preparations; design and development of computer databases; software design services relating to data processing test tools; provision of information and data relating to medical and veterinary research and development; technical data analysis services, namely, data analysis for medicine and pharmaceutical testing, research and development purposes; information, advice and consultancy in relation to all the aforesaid services, namely, providing information in the field of research and development of pharmaceutical preparations; Software as a service (SAAS) services featuring software in relation to data management, data analysis, data manipulation, and medicine and pharmaceutical testing, research and development services; Software as a service (SAAS) services featuring software in relation to communication between laboratory networks and diagnostic and pharmaceutical companies; Software as a service (SAAS) services featuring software in relation to data management and visualisation, for generating reports, charts and dashboards; Platform as a service (PAAS) featuring computer software platforms for use in relation to data management, data analysis, data manipulation, and medicine and pharmaceutical testing, research and development services; Platform as a service (PAAS) featuring computer software platforms for use in relation to communication between laboratory networks and diagnostic and pharmaceutical companies; Platform as a service (PAAS) featuring computer software platforms for use in relation to data management and visualisation for generating reports, charts and dashboards; information, advice and consultancy in relation to all the aforesaid services

Owner

Prosecution history

  • 26 Oct 2021 — REGISTERED-PRINCIPAL REGISTER
  • 10 Aug 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 10 Aug 2021 — PUBLISHED FOR OPPOSITION
  • 21 Jul 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 07 Jul 2021 — LAW OFFICE PUBLICATION REVIEW COMPLETED
  • 07 Jul 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 24 Jun 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 24 Jun 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 24 Jun 2021 — ASSIGNED TO LIE
  • 12 Apr 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 18 Mar 2021 — NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
  • 18 Mar 2021 — EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
  • 18 Mar 2021 — COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
  • 18 Mar 2021 — EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
  • 21 Sept 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED

View this trademark record on Marksy